| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Cross Shawn is a Chief Financial Officer at Pacira BioSciences, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | PCRX Pacira Biosciences, Inc. | Chief Financial Officer | Sale+OE | 12,941 | $25.16 | $325,595.56 | -10.9% | - | - | |
| Apr 22, 2026 | PCRX Pacira Biosciences, Inc. | Chief Financial Officer | Sale+OE | 12,059 | $25.09 | $302,598.41 | -3.7% | - | - | |
| Dec 10, 2025 | PCRX Pacira Biosciences, Inc. | Chief Financial Officer | Sale+OE | 25,000 | $25.07 | $626,751.44 | -18.2% | -10.9% | - | |
| Nov 10, 2025 | PCRX Pacira Biosciences, Inc. | Chief Financial Officer | Sell | 12,060 | $22.09 | $266,405.40 | -17.7% | -8.7% | - |